Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Refractory Acute Lymphoblastic Leukemia
0.030 GeneticVariation disease BEFREE Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia. 31477025 2019
Refractory Acute Lymphoblastic Leukemia
0.030 Biomarker disease BEFREE Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia. 29633386 2018
Refractory Acute Lymphoblastic Leukemia
0.030 Biomarker disease BEFREE Thus, treatment with CAR-T cells followed by allo-HSCT may be the best way to treat relapsed/refractory ALL. 29032733 2017